FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma
Advanced Science · 2026-08 · 13 (44)
DOI: 10.1002/advs.202523667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.06.2026. Verfasst von Lu Chen und 18 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Lung Neoplasms, Adenocarcinoma of Lung, Cellular Senescence. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian grant, Shenzhen Science and Technology Research and Development Project.
Abstract (Originalsprache)
While targeted therapies have improved outcomes in lung adenocarcinoma (LUAD), many patients still lack targetable mutations. Here, we identified alpha‐L‐fucosidase 2 (FUCA2) as a crucial driver of LUAD by preventing cellular senescence. Mechanistically, through the restriction of fucosyltransferase 3 (FUT3)‐mediated α‐1,3‐fucosylation of ErbB3 at Asn437, FUCA2 safeguarded ErbB3–ErbB2 heterodimerization to promote ErbB3 activation and sustain persistent AKT signaling. Active AKT prevented p53 protein stabilization in TP53‐wild‐type LUAD cells and inhibited p27 protein accumulation in TP53‐mutant LUAD cells, thereby counteracting senescence and supporting malignant growth. Notably, low‐dose Capivasertib, an AKT inhibitor targeting tumors with PIK3CA/AKT1/PTEN mutation(s), induced senescence selectively in FUCA2‐high LUAD irrespective of PIK3CA/AKT1/PTEN/TP53 mutational status, and its combination with the nutraceutical senolytic procyanidin C1 achieved potent and low‐toxicity suppression of LUAD across multiple preclinical models. Together, our results uncover the FUCA2–ErbB3 fucosylation–AKT pathway as a central regulator of senescence and propose a FUCA2‐guided drug repurposing strategy for LUAD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Research Center, School of Medicine, Xiamen University, Xiamen, China.
- National Institute for Data Science in Health and Medicine, School of Medicine, Xiamen University, Xiamen, China.
- Shandong Provincial Key Medical and Health Laboratory of BT and IT for Thoracic Oncology, The First Affiliated Hospital of Shandong Second Medical University, Weifang, China.
- Department of Respiratory, Critical Care and Sleep Medicine, School of Medicine, Xiang'an Hospital of Xiamen University, Xiamen University, Xiamen, China.
- Department of Oncology, School of Medicine, Zhongshan Hospital of Xiamen University, Xiamen University, Xiamen, China.
- School of Food Science and Technology, Jiangnan University, Wuxi, China.
ORCID-Profile: Yan-Yan Zhan
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian grant
- Shenzhen Science and Technology Research and Development Project
- Xiang'an Innovation Laboratory/National Key Laboratory of Infectious Disease Vaccine Research and Development Science and Technology Project
Zitieren
APA
Chen, L., Guo, J., Li, F., Gao, M., Li, R., Huang, Z., Zheng, Y., Gao, C., Hou, J., Yu, Q., Zheng, B., Chen, X., Zhang, W., Hong, X., Zheng, Y., Wang, D., Li, Q., Hu, T., & Zhan, Y. Y. (2026). FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma. Advanced Science, 13(44). https://doi.org/10.1002/advs.202523667
Vancouver
Chen L, Guo J, Li F, Gao M, Li R, Huang Z, et al. FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma. Advanced Science. 2026;13(44). doi:10.1002/advs.202523667
BibTeX
@article{Chen2026,
author = {Chen, Lu and Guo, Jintao and Li, Fei and Gao, Mingjie and Li, Runyang and Huang, Zhaozhang and Zheng, Yaolin and Gao, Chunyi and Hou, Jihuan and Yu, Qiang and Zheng, Bowen and Chen, Xuemei and Zhang, Wenqing and Hong, Xiaoting and Zheng, Yali and Wang, Daxuan and Li, Qiyuan and Hu, Tianhui and Zhan, Yan-Yan},
title = {FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {44},
doi = {10.1002/advs.202523667}
}
EUVIMED